OHR Pharmaceutical Inc Share Price Nasdaq
Equities
US67778H2004
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 13.79L 11Cr |
---|---|---|---|---|---|
Net income 2023 * | -1.2Cr -100Cr | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
1st Jan change | Capi. | |
---|---|---|
+58.54% | 5.51TCr | |
-1.95% | 4.18TCr | |
+44.36% | 4.02TCr | |
-8.29% | 2.82TCr | |
+12.15% | 2.63TCr | |
-21.09% | 1.89TCr | |
+6.89% | 1.3TCr | |
+28.36% | 1.23TCr | |
+25.69% | 1.22TCr |